Loading clinical trials...
Loading clinical trials...
A Phase II Study of Total or Subtotal Colectomy in Stage IIIC and Stage IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (EOC, FTC, PPC)
The purpose of this study is to evaluate the safety and one year disease-free survival of total or subtotal colectomy and proctocolectomy in stage IIIc and stage IV epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC, FTC, PPC).
This trial is to assess the perioperative complications, hospitalization expenses and days, and one year disease-free survival of patients who underwent total or subtotal colectomy as part of the surgical procedures for ovarian cancer, versus partial intestinal resection in the therapy for ovarian cancer.
Age
18 - 75 years
Sex
FEMALE
Healthy Volunteers
No
Fudan University Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Start Date
July 1, 2015
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2018
Last Updated
July 26, 2016
80
ESTIMATED participants
Total or Subtotal Colectomy
PROCEDURE
Other Bowel Resection
PROCEDURE
Lead Sponsor
Shanghai Gynecologic Oncology Group
Collaborators
NCT04657068
NCT05281471
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions